Dieter Willbold

Scientia Ventures LLC (Scientia Ventures) is a venture capital firm founded in 2006 by Jonathan Finn. The firm is headquartered in New York.

The National Research Council provides science, technology and health policy consulting and advice. The company was founded in 1916 and is headquartered in Washington, DC.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

Part of Charles River Laboratories International, Inc., NewLab BioQuality AG is a laboratory services provider that specializes in the analysis of biopharmaceutical drugs. The company is based in Erkrath, Germany. The German company was founded by Jürgen Schumacher. Jürgen Schumacher has been the CEO since incorporation. NewLab BioQuality was acquired by Charles River Laboratories International, Inc. on September 09, 2008 for $52.65 million.

DRK-Blutspendedienst West Gemeinnützige GmbH is a private company based in Muenster, Germany. The German company provides blood donation services that are simple, environmentally friendly, and efficient. The company offers intelligent tools and services to help donors manage their donations and answer any questions they may have. The company also provides a downloadable form for reporting transfusion reactions. Donors can sign up to receive email invitations to their donation appointments.

evocatal GmbH operates as a biotechnology company. The firm specializes in the development and production of tailor-made biocatalysts and fine chemicals. Its products include carbohydrates enzymes, fine chemicals, and evoglow. The company was founded by Thorsten Eggert in August 2006 and is headquartered in Monheim am Rhein, Germany.

DIREVO Industrial Biotechnology GmbH provides bioengineering services for industrial, molecular biology, and reaction chemistry applications. It offers enzyme and strain engineering, application development, and process engineering services. The firm also offers research and development services for bio-fuel production. The company was founded in July 2008 and is headquartered in Cologne, Germany.

NUMAFERM GmbH specializes in the biotechnical production of peptides. The firm focuses on pharmaceutical, antimicrobial and adhesives peptides. Its services include feasibility study, custom synthesis, peptide development, up scaling, and licensing services. The company was founded by Philipp Bürling and Karl Christian Werner Schwarz in January 2017 and is headquartered in Dusseldorf, Germany.